Department of Gynecology, 4501Leiden University Medical Center, Leiden, The Netherlands.
Department of Surgery, 10233Jeroen Bosch Hospital, Den Bosch, The Netherlands.
Surg Innov. 2022 Feb;29(1):73-79. doi: 10.1177/15533506211003527. Epub 2021 Mar 31.
During the COVID-19 pandemic the question arises if laparoscopy, as an aerosol forming procedure, poses a potential risk for viral transmission of SARS-CoV-2 to healthcare workers. A literature search was conducted using PubMed, Embase and MEDLINE. Articles reporting information regarding COVID-19 or other relevant viruses and laparoscopy, surgical smoke, aerosols and viral transmission were included. Although aerosols produced during laparoscopy do not originate from the respiratory tract, the main transmission route of SARS-CoV-2, research did show SARS-CoV-2 to be present in other body fluids. The transmission risk via this route is however considered very low. As previous research showed potential viral transmission during laparoscopy for viruses that spread through contaminated body fluids, there might be a potential risk of SARS-CoV-2 transmission during laparoscopy, albeit considered very small. Due to the small risk compared to widely known benefits of laparoscopy, there is no reason to replace laparoscopy by laparotomy due to COVID-19 infection. To avoid the potential small risk of viral transmission, additional safety measures are advised.
在 COVID-19 大流行期间，人们提出疑问，作为一种产生气溶胶的程序，腹腔镜手术是否会对 SARS-CoV-2 病毒向医护人员的传播构成潜在风险。使用 PubMed、Embase 和 MEDLINE 进行了文献检索。纳入了报告有关 COVID-19 或其他相关病毒以及腹腔镜手术、手术烟雾、气溶胶和病毒传播信息的文章。尽管腹腔镜手术过程中产生的气溶胶并非源自 SARS-CoV-2 的主要传播途径（呼吸道），但研究表明 SARS-CoV-2 存在于其他体液中。然而，通过这种途径传播的风险被认为非常低。由于先前的研究表明，腹腔镜手术可能会传播通过污染体液传播的病毒，因此在腹腔镜手术过程中可能存在 SARS-CoV-2 传播的风险，尽管被认为非常小。由于与腹腔镜手术的广泛益处相比，风险很小，因此没有理由因 COVID-19 感染而将腹腔镜手术改为剖腹手术。为了避免潜在的病毒传播风险，建议采取额外的安全措施。
